Profil
Richard A. F.
Dixon is the founder of 7 Hills Pharma LLC.
Prior to founding 7 Hills Pharma LLC, he worked as the Chief Scientific Officer & SVP-Research at Encysive Pharmaceuticals, Inc. from 1990 to 2011.
Before that, he was the Director & Head-Molecular Biology at Merck Sharp & Dohme Research Laboratories from 1988 to 1990.
Dixon received his undergraduate degree from Texas A&M University and his doctorate from Baylor College of Medicine.
Postes actifs de Richard A. F. Dixon
| Sociétés | Poste | Début |
|---|---|---|
7 Hills Pharma LLC
7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer treatment | Fondateur | - |
Anciens postes connus de Richard A. F. Dixon
| Sociétés | Poste | Fin |
|---|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Directeur Technique/Scientifique/R&D | 29/04/2011 |
Merck Sharp & Dohme Research Laboratories | Directeur/Membre du Conseil | 01/01/1990 |
Formation de Richard A. F. Dixon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Encysive Pharmaceuticals, Inc.
Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases | Health Technology |
Texas A&M University
Texas A&M University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Sharp & Dohme Research Laboratories | |
7 Hills Pharma LLC
7 Hills Pharma LLC Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer treatment | Health Technology |
















